Marcus E. Smith
Compliance Officer at Third Security LLC
Profile
Mr. Smith joined Third Security upon its inception and has since been principally responsible for legal matters and transaction execution.
Since February 2020, Mr. Smith has served as President of Eleszto Genetika, Inc. and as President of GreenVenus, L.L.C.
Mr. Smith served as a member of the Board of Directors of Fibrocell Science, Inc. (previously traded on Nasdaq prior to its acquisition by Castle Creek Pharmaceutical Holdings in December 2019) from October 2012 until December 2019.
Mr. Smith has served in various other capacities, including as Senior Vice President, General Counsel, Secretary and member of the Board of Directors of New River Pharmaceuticals Inc. from August 1996 until April 2004, as Senior Vice President, General Counsel, Secretary and member of the Board of Directors of General Injectables & Vaccines, Inc. between 1994 and 1998 and as Senior Vice President, General Counsel, Secretary and member of the Board of Directors of GIV Holdings, Inc. between 1996 and 1998.
Previously he was an attorney in the legal departments of The Southland Corporation and Occidental Oil & Gas Corporation.
Mr. Smith received a BBA and a JD from the University of Georgia.
Marcus E. Smith active positions
| Companies | Position | Start |
|---|---|---|
Third Security LLC
 Third Security LLC Investment ManagersFinance Third Security LLC (Third Security) is a private equity firm founded in 1999 by Randal J. Kirk. The firm is headquartered in Radford, Virginia. | Compliance Officer | 1998-12-31 |
Former positions of Marcus E. Smith
| Companies | Position | End |
|---|---|---|
| FIBROCELL SCIENCE, INC. | Director/Board Member | 2019-12-12 |
ECDS LLC
 ECDS LLC Packaged SoftwareTechnology Services ECDS LLC provides automated, proactive notification software and services. Its solutions are deployed in diverse IT environments, including health care, government, telecommunications, retail and education. The company was founded in 1998 and is headquartered in Scotts Valley, CA. | Corporate Officer/Principal | 2008-06-29 |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Corporate Officer/Principal | 2004-04-29 |
General Injectables & Vaccines, Inc.
 General Injectables & Vaccines, Inc. Medical DistributorsDistribution Services Part of Henry Schein, Inc., General Injectables & Vaccines, Inc. is a supplier of vaccines. The company is based in Bastian, VA. General Injectables & Vaccines was acquired by Henry Schein, Inc. on December 29, 1998 for $145 million. The company was founded by Randal J. Kirk. | Corporate Officer/Principal | 1997-12-31 |
| GIV Holdings, Inc. | Corporate Officer/Principal | 1997-12-31 |
Training of Marcus E. Smith
| University of Georgia | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Third Security LLC
Third Security LLC Investment ManagersFinance Third Security LLC (Third Security) is a private equity firm founded in 1999 by Randal J. Kirk. The firm is headquartered in Radford, Virginia. | Finance |
ECDS LLC
ECDS LLC Packaged SoftwareTechnology Services ECDS LLC provides automated, proactive notification software and services. Its solutions are deployed in diverse IT environments, including health care, government, telecommunications, retail and education. The company was founded in 1998 and is headquartered in Scotts Valley, CA. | Technology Services |
New River Pharmaceuticals, Inc.
New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Health Technology |
General Injectables & Vaccines, Inc.
General Injectables & Vaccines, Inc. Medical DistributorsDistribution Services Part of Henry Schein, Inc., General Injectables & Vaccines, Inc. is a supplier of vaccines. The company is based in Bastian, VA. General Injectables & Vaccines was acquired by Henry Schein, Inc. on December 29, 1998 for $145 million. The company was founded by Randal J. Kirk. | Distribution Services |
| GIV Holdings, Inc. | |
| Occidental Oil & Gas Corp. | |
Fibrocell Science, Inc.
 Fibrocell Science, Inc. Pharmaceuticals: MajorHealth Technology Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on December 28, 1995 and is headquartered in Exton, PA. | Health Technology |
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
- Stock Market
- Insiders
- Marcus E. Smith
